» Authors » Lucian Petrescu

Lucian Petrescu

Explore the profile of Lucian Petrescu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 495
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ionica L, Linta A, Batrin A, Hancu I, Lolescu B, Danila M, et al.
Int J Mol Sci . 2024 Jul; 25(14). PMID: 39062954
Sodium-glucose cotransporter 2 inhibitors (SGLT2i), a novel class of glucose-lowering drugs, have revolutionized the management of heart failure with reduced and preserved ejection fraction, regardless of the presence of diabetes,...
2.
Ionica L, Buriman D, Linta A, Sosdean R, Lascu A, Streian C, et al.
Mol Cell Biochem . 2024 Jul; 480(3):1645-1655. PMID: 39042348
The sodium-glucose-cotransporter 2 inhibitors (SGLT2i) are the blockbuster antidiabetic drugs that exert cardiovascular protection via pleiotropic effects. We have previously demonstrated that empagliflozin decreased monoamine oxidase (MAO) expression and oxidative...
3.
Goanta E, Vacarescu C, Tartea G, Ungureanu A, Militaru S, Muraretu A, et al.
J Clin Med . 2024 Jul; 13(13). PMID: 38999368
To assess the frequency and types of genetic mutations in patients with arrhythmias who underwent cardiac device implantation. Retrospective observational study, including 38 patients with different arrhythmias and cardiac arrest...
4.
Rachieru C, Lighezan D, Petrescu L, Tartea G, Goanta E, Buzas R, et al.
Curr Health Sci J . 2024 Jun; 50(1):59-66. PMID: 38846471
Aim: The aim of the study was to assess the inflammatory status in individuals diagnosed with atrial fibrillation (Afi) and establish an association between this status and the clinicopathological features....
5.
Rachieru C, Lighezan D, Petrescu L, Tartea E, Goanta E, Buzas R, et al.
Curr Health Sci J . 2024 Apr; 49(4):571-578. PMID: 38559827
Aim: The aim of our study was to retrospectively evaluate known factors such as CHA2DS2-VASc, but, also, new factors (such as left atrial remodeling), associated with the development of stroke...
6.
Gurgu A, Petrescu L, Luca C, Vacarescu C, Tartea G, Goanta E, et al.
Curr Health Sci J . 2024 Apr; 49(4):479-486. PMID: 38559824
Triple-chamber cardiac devices are utilized for cardiac resynchronization therapy (CRT) and is the standard-of-care therapy for heart failure (HF) patients in the current guidelines. In the setting of biventricular (BIV)...
7.
Rachieru C, Luca C, Vacarescu C, Petrescu L, Cirin L, Cozma D
Clin Interv Aging . 2023 Oct; 18:1737-1748. PMID: 37873054
In 10% of ischemic strokes, non-valvular atrial fibrillation (NVAF) is detected retroactively. Milder, or even asymptomatic forms of NVAF have shown high mortality, thrombotic risk, and deterioration of cognitive function....
8.
Goanta E, Ungureanu A, Tartea G, Muraretu A, Manciu D, Vacarescu C, et al.
Curr Health Sci J . 2023 Oct; 49(2):230-236. PMID: 37779829
Background: Remote monitoring (RM) is becoming a standard of care for patients with cardiac resynchronization therapy (CRT). This technology combines the use of pacemakers or implantable cardioverter-defibrillators (ICD) and wireless...
9.
Lazar M, Ionac I, Luca C, Petrescu L, Vacarescu C, Crisan S, et al.
Diagnostics (Basel) . 2023 Sep; 13(18). PMID: 37761263
Background: The left ventricular (LV) remodelling process represents the main cause of heart failure after a ST-segment elevation myocardial infarction (STEMI). Speckle-tracking echocardiography (STE) can detect early deformation impairment, while...
10.
Betiu A, Lighezan R, Avram V, Muntean D, Elmer E, Petrescu L
Mol Cell Biochem . 2023 Jul; 479(6):1501-1512. PMID: 37486451
Acetaminophen and ibuprofen are widely used over-the-counter medications to reduce fever, pain, and inflammation. Although both drugs are safe in therapeutic concentrations, self-medication is practiced by millions of aged patients...